The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uzonna, J. E.
Right arrow Articles by Scott, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uzonna, J. E.
Right arrow Articles by Scott, P.
The Journal of Immunology, 2004, 172: 3793-3797.
Copyright © 2004 by The American Association of Immunologists

Vaccination with Phosphoglycan-Deficient Leishmania major Protects Highly Susceptible Mice from Virulent Challenge without Inducing a Strong Th1 Response1

Jude E. Uzonna*, Gerald F. Späth2,{dagger}, Stephen M. Beverley{dagger} and Phillip Scott3,*

* Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104; and {dagger} Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110

Long-term immunity to Leishmania may require the continued presence of parasites, but previous attempts to create attenuated parasites that persist without causing disease have had limited success. Since Leishmania major mutants that lack lipophosphoglycan and other secreted phosphoglycans, termed lpg2-, persist indefinitely in infected mice without inducing any disease, we tested their ability to provide protection to virulent L. major challenge. In response to leishmanial Ag stimulation, cells from lpg2--infected mice produced minimal levels of IL-4 and IL-10, as well as very low levels of IFN-{gamma}. Nevertheless, when BALB/c mice infected with lpg2- parasites were challenged with virulent L. major they were protected from disease. Thus, these findings report on attenuated parasites that may be used to induce long-term protection against leishmaniasis and indicate that the immunity induced can be maintained in the absence of a strong Th1 response.




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
D. Liu, C. Kebaier, N. Pakpour, A. A. Capul, S. M. Beverley, P. Scott, and J. E. Uzonna
Leishmania major Phosphoglycans Influence the Host Early Immune Response by Modulating Dendritic Cell Functions
Infect. Immun., August 1, 2009; 77(8): 3272 - 3283.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Kamala and N. K. Nanda
Protective Response to Leishmania major in BALB/c Mice Requires Antigen Processing in the Absence of DM
J. Immunol., April 15, 2009; 182(8): 4882 - 4890.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. A. Capul, S. Hickerson, T. Barron, S. J. Turco, and S. M. Beverley
Comparisons of Mutants Lacking the Golgi UDP-Galactose or GDP-Mannose Transporters Establish that Phosphoglycans Are Important for Promastigote but Not Amastigote Virulence in Leishmania major
Infect. Immun., September 1, 2007; 75(9): 4629 - 4637.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Silvestre, A. Cordeiro-Da-Silva, N. Santarem, B. Vergnes, D. Sereno, and A. Ouaissi
SIR2-Deficient Leishmania infantum Induces a Defined IFN-{gamma}/IL-10 Pattern That Correlates with Protection
J. Immunol., September 1, 2007; 179(5): 3161 - 3170.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Boitz and B. Ullman
A Conditional Mutant Deficient in Hypoxanthine-guanine Phosphoribosyltransferase and Xanthine Phosphoribosyltransferase Validates the Purine Salvage Pathway of Leishmania donovani
J. Biol. Chem., June 9, 2006; 281(23): 16084 - 16089.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Naderer, M. A. Ellis, M. F. Sernee, D. P. De Souza, J. Curtis, E. Handman, and M. J. McConville
Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase
PNAS, April 4, 2006; 103(14): 5502 - 5507.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Kebaier, J. E. Uzonna, S. M. Beverley, and P. Scott
Immunization with Persistent Attenuated {Delta}lpg2 Leishmania major Parasites Requires Adjuvant To Provide Protective Immunity in C57BL/6 Mice
Infect. Immun., January 1, 2006; 74(1): 777 - 780.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Breton, M. J Tremblay, M. Ouellette, and B. Papadopoulou
Live Nonpathogenic Parasitic Vector as a Candidate Vaccine against Visceral Leishmaniasis
Infect. Immun., October 1, 2005; 73(10): 6372 - 6382.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. S. Tabbara, N. C. Peters, F. Afrin, S. Mendez, S. Bertholet, Y. Belkaid, and D. L. Sacks
Conditions Influencing the Efficacy of Vaccination with Live Organisms against Leishmania major Infection
Infect. Immun., August 1, 2005; 73(8): 4714 - 4722.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. F. Spath, L.-F. Lye, H. Segawa, S. J. Turco, and S. M. Beverley
Identification of a Compensatory Mutant (lpg2-REV) of Leishmania major Able To Survive as Amastigotes within Macrophages without LPG2-Dependent Glycoconjugates and Its Significance to Virulence and Immunization Strategies
Infect. Immun., June 1, 2004; 72(6): 3622 - 3627.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.